Bridgebio Pharma Inc Revenue per Employee (BBIO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bridgebio Pharma Inc   (NASDAQ: BBIO)
 

Bridgebio Pharma Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Bridgebio Pharma Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,126,985, below the company average number of $227,539.
Within the Healthcare sector Employees of 126 other companies have achieved higher revenue per employee. While Bridgebio Pharma Inc 's total ranking has deteriorated compared to the previous quarter from 1093 to 1207. Bridgebio Pharma Inc has 839 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BBIO Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 192.6 % 120.39 % 66.78 % 2521.18 % 4318.01 %
Sales per Employee (TTM) $ 1,126,985 849,903 691,249 598,422 421,669
BBIO's Total Ranking # 1207 # 1093 # 875 # 110 #
Seq. Revenue Change 44.93 % 25.27 % 26.16 % 27.74 % 9.17 %

BBIO Company Profile >> Back to BBIO Efficiency Comparisons >> Compare BBIO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 86
Healthcare Sector # 127
Overall Market # 1207

Revenue per Employee Statistics
High Average Low
$ 849,903 $ 227,539 $ 6,764
(Jun 30 2026)   (Jun 30 2023)



Financial Statements
Bridgebio Pharma Inc 's Revenue MRQ $ 353 Millions Visit BBIO's Income Statement
Bridgebio Pharma Inc 's Revenues TTM $ 946 Millions Visit BBIO's aggregate revenue growth
What are BBIO's Sales? Visit BBIO's Sales by Segment




Other Ratios
Bridgebio Pharma Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BBIO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BBIO's Competitors
Revenue per Employee for BBIO's Suppliers
Revenue per Employee for BBIO's Customers

You may also want to know
BBIO's Sales Growth Rates BBIO's Pe Price to earnings ratio BBIO's Receivables Turnover Ratio BBIO's Stock Quote
BBIO's Net Income Growth Rates BBIO's Ps Price to Sales ratio BBIO's Sales per Employee BBIO's Asset Turnover Ratio
BBIO's Net Margin BBIO's Pb Price to Book ratio BBIO's Financial Strength Ratios BBIO's Dividend Payout Ratio
Date modified: 2026-10-30T17:01:30+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Arvinas Inc   1,119,105.69 $ 275.300  Million 246 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Ani Pharmaceuticals Inc  1,073,549.48 $ 1,041.343  Million 970 
Verastem Inc   983,294.12 $ 100.296  Million 102 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.